As we all know, after anti-programmed cell death protein 1/programmed cell death ligand 1 (PD-1/PD-L1) got satisfying results in most cancers, CTLA-4 has also made breakthroughs in the immunotherapy of various tumors. This evidence concerns the gene CD274 and cancer.